{
    "nctId": "NCT00897962",
    "briefTitle": "Blood Glycan Biomarkers in Women With Stage IV Breast Cancer",
    "officialTitle": "Serum Glycan Analysis in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 163,
    "primaryOutcomeMeasure": "Profiling serum glycan biomarkers in patients with metastatic breast cancer, healthy controls, and patients with noncancer medical illness",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Patient or participant at the Women's Health Clinic, the Internal Medicine Clinic, or at the UC Davis Cancer Center, meeting 1 of the following criteria:\n\n  * Diagnosis of stage IV metastatic breast cancer, receiving active treatment with chemotherapy, endocrine therapy, or targeted therapy\n  * Patients/participants without cancer\n\n    * Healthy control being seen for annual exams, meeting the following criteria:\n\n      * No chronic disease\n      * Not on regular prescribed medications\n    * Patient without cancer being seen in the Internal Medicine Clinic\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* Not pregnant or breast feeding\n* No other active cancer\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}